FF2039
FF2039 (compound 1j) is a specific HDAC1, HDAC6, and HDAC isoforms of class I, IIa and IIb PROTAC degrader. FF2039 demonstrates s significant antiproliferative activity against both hematological and solid cancer cell lines, driven by cell cycle arrest and Apoptosis induction. FF2039 inhibits HDAC isoform of HDAC1, HDAC2, HDAC4 and HDAC6 with IC50s of 1.03, 2.15, 12.4 and 0.053 μM, respectively. FF2039 shows antiproliferative activity against different tumor entities of MM.1S, MDA-MB-231 and U-87MG with EC50s of 2.8, 28 and 30 μM, respectively. (Pink: PRMT5 ligand (HY-168864) ; Blue: E3 ligase ligand HY-W957284) ; Black: linker (HY-W881439) ; E3+linker (HY-172185) ) [1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; HDAC
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(NCCCCCCC(NO)=O)C1=CC=C(NC(CCCCCCCCCCCN(C(C2=CC=C(Cl)C(Cl)=C2)C(NCC3=CC=CC=C3)=O)C(CCl)=O)=O)C=C1
Molecular Formula
C43H56Cl3N5O6
Molecular Weight
845.29
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC2; HDAC4; HDAC6
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items